Trial to Evaluate the Effect of Eslicarbazepine Acetate on Cardiac Repolarization
Status:
Completed
Trial end date:
2007-06-01
Target enrollment:
Participant gender:
Summary
A randomized, double-blind, placebo-controlled and open label active-controlled, 4 period
crossover trial to evaluate the effect of eslicarbazepine acetate on cardiac repolarization
in healthy adult men and women
Phase:
Phase 1
Details
Lead Sponsor:
Bial - Portela C S.A.
Treatments:
Eslicarbazepine acetate Moxifloxacin Norgestimate, ethinyl estradiol drug combination